SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001839882-23-017505
Filing Date
2023-07-03
Accepted
2023-07-03 16:20:04
Documents
1
Group Members
AFFINITY HEALTHCARE FUND, LP

Document Format Files

Seq Description Document Type Size
1 ACQUISITION OF BENEFICIAL OWNERSHIP affin-sc13g_070323.htm SC 13G 96954
  Complete submission text file 0001839882-23-017505.txt   98520
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89456 | Film No.: 231065465
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 THIRD AVENUE 15TH FLOOR NEW YORK NY 10017
Business Address 767 THIRD AVENUE 15TH FLOOR NEW YORK NY 10017 917-826-4533
Affinity Asset Advisors, LLC (Filed by) CIK: 0001773195 (see all company filings)

IRS No.: 821567490 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G